![]() |
市场调查报告书
商品编码
1459522
全球血管栓塞器械市场 2024-2028Global Vascular Embolization Devices Market 2024-2028 |
血管栓塞设备市场预计在 2023-2028 年期间成长 7.3535 亿美元,预测期内复合年增长率为 6.69%。
该报告包括对血管栓塞器械市场的总体分析、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的驱动因素包括血管疾病盛行率的增加、与血管栓塞装置相关的新产品的推出数量的增加以及相关血管疾病产品的併购的增加。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 5.94% |
复合年增长率 | 6.69% |
增量 | 7.3535亿美元 |
研究指出,车祸的增加是未来几年推动血管栓塞设备市场成长的关键因素之一。此外,创业投资和政府组织对新兴栓塞设备公司的资助,以及栓塞产品和程序的创新,将带来巨大的市场需求。
The vascular embolization devices market is forecasted to grow by USD 735.35 mn during 2023-2028, accelerating at a CAGR of 6.69% during the forecast period. The report on the vascular embolization devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of vascular diseases, a rising number of new product launches related to vascular embolization devices, and a growing number of m and activities in related vascular disease products.
Technavio's vascular embolization devices market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 5.94% |
CAGR | 6.69% |
Incremental Value | $735.35mn |
By End-user
By Product
By Geographical Landscape
This study identifies the rise in cases of automobile accidents as one of the prime reasons driving the vascular embolization devices market growth during the next few years. Also, funding for start-up embolization device companies from venture capitalists and government organizations and innovation in embolization products and procedures will lead to sizable demand in the market.
The report on the vascular embolization devices market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular embolization devices market vendors that include Acandis GmbH, B.Braun SE, BALT Group, Boston Scientific Corp., Braile Biomedica, Eisai Co. Ltd., Embolx Inc., Guerbet, Johnson and Johnson Services Inc., Kaneka Corp., Medtronic, Merit Medical Systems Inc., Penumbra Inc., Shape Memory Medical Inc., Spartan Micro Inc., Stryker Corp., Wallby Medical LLC, Terumo Corp., Cook Group Inc., and Abbott Laboratories. Also, the vascular embolization devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: